Reported Standalone quarterly numbers for AstraZeneca Pharma are:Net Sales at Rs 190.30 crore in March 2019 up 26.26% from Rs. 150.73 crore in March 2018.
Quarterly Net Profit at Rs. 9.82 crore in March 2019 up 204.95% from Rs. 3.22 crore in March 2018.
EBITDA stands at Rs. 12.38 crore in March 2019 down 29.7% from Rs. 17.61 crore in March 2018.
AstraZeneca EPS has increased to Rs. 3.93 in March 2019 from Rs. 1.29 in March 2018.
AstraZeneca shares closed at 2,225.35 on May 23, 2019 (NSE) and has given 60.84% returns over the last 6 months and 88.26% over the last 12 months.
| AstraZeneca Pharma |
| Standalone Quarterly Results |
in Rs. Cr. |
|
|
Mar'19 |
Dec'18 |
Mar'18 |
| Net Sales/Income from operations |
190.30 |
215.19 |
150.73 |
| Other Operating Income |
-- |
-- |
-- |
| Total Income From Operations |
190.30 |
215.19 |
150.73 |
| EXPENDITURE |
| Consumption of Raw Materials |
22.24 |
16.84 |
11.49 |
| Purchase of Traded Goods |
80.92 |
41.57 |
24.73 |
| Increase/Decrease in Stocks |
-40.28 |
6.51 |
7.84 |
| Power & Fuel |
-- |
-- |
-- |
| Employees Cost |
60.41 |
52.11 |
45.07 |
| Depreciation |
3.91 |
3.78 |
3.55 |
| Excise Duty |
-- |
-- |
-- |
| Admin. And Selling Expenses |
22.98 |
16.51 |
21.11 |
| R & D Expenses |
-- |
-- |
-- |
| Provisions And Contingencies |
-- |
-- |
-- |
| Exp. Capitalised |
-- |
-- |
-- |
| Other Expenses |
37.67 |
40.77 |
25.22 |
| P/L Before Other Inc. , Int., Excpt. Items & Tax |
2.46 |
37.10 |
11.72 |
| Other Income |
6.01 |
3.50 |
2.34 |
| P/L Before Int., Excpt. Items & Tax |
8.47 |
40.59 |
14.06 |
| Interest |
-- |
-- |
-- |
| P/L Before Exceptional Items & Tax |
8.47 |
40.59 |
14.06 |
| Exceptional Items |
-- |
-- |
-- |
| P/L Before Tax |
8.47 |
40.59 |
14.06 |
| Tax |
-1.35 |
11.50 |
10.84 |
| P/L After Tax from Ordinary Activities |
9.82 |
29.09 |
3.22 |
| Prior Year Adjustments |
-- |
-- |
-- |
| Extra Ordinary Items |
-- |
-- |
-- |
| Net Profit/(Loss) For the Period |
9.82 |
29.09 |
3.22 |
| Equity Share Capital |
5.00 |
5.00 |
5.00 |
| Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
| Equity Dividend Rate (%) |
-- |
-- |
-- |
| EPS Before Extra Ordinary |
| Basic EPS |
3.93 |
11.64 |
1.29 |
| Diluted EPS |
3.93 |
11.64 |
1.29 |
| EPS After Extra Ordinary |
| Basic EPS |
3.93 |
11.64 |
1.29 |
| Diluted EPS |
3.93 |
11.64 |
1.29 |
| Public Share Holding |
| No Of Shares (Crores) |
-- |
-- |
-- |
| Share Holding (%) |
-- |
-- |
-- |
| Promoters and Promoter Group Shareholding |
| a) Pledged/Encumbered |
| - Number of shares (Crores) |
-- |
-- |
-- |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
| b) Non-encumbered |
| - Number of shares (Crores) |
-- |
-- |
-- |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
| Source : Dion Global Solutions Limited |
|
Get Lok Sabha 2019 Live Election Results, constituency-wise tally, news, views and analysis
Follow our Lok Sabha Election Result Live Blog here.
